Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of PX-866 and Docetaxel in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01204099
Recruitment Status : Completed
First Posted : September 17, 2010
Last Update Posted : May 16, 2018
Information provided by (Responsible Party):
Seagen Inc. ( Cascadian Therapeutics Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2013
Actual Study Completion Date : February 2014
Certification/Extension First Submitted : April 30, 2015